Table 4.
Outcomes | Change from Baseline Outcome | |||||||
---|---|---|---|---|---|---|---|---|
I, Mean (SD) | C, Mean (SD) | I, Mean (SE) | C, Mean (SE) | I-C Difference (95% CI) | p-Value | |||
Baseline | 8 Weeks | Baseline | 8 Weeks | |||||
Body Composition | ||||||||
Enjoyment | 1.8 (0.9) |
2.4 (1.2) | 1.6 (0.8) |
2.0 (1.1) | 0.6 (0.2) | 0.3 (0.2) |
0.3 (−0.3, 0.8) | 0.39 |
Self-efficacy | 3.7 (0.8) |
3.3 (1.0) | 3.7 (0.8) |
3.6 (1.0) | −0.4 (0.2) | −0.1 (0.1) | −0.3 (−0.8, 0.1) | 0.17 |
SSFR | 2.0 (1.0) |
2.2 (1.2) | 2.2 (1.1) |
2.3 (1.3) | 0.1 (0.2) | 0.2 (0.2) |
−0.1 (−0.6, 0.6) | 0.85 |
SSFA | 2.6 (1.1) |
2.7 (1.2) | 2.8 (1.1) |
2.5 (1.2) | 0.1 (0.2) | −0.2 (0.2) | 0.3 (−0.3, 0.9) | 0.31 |
Note. Outcome values at baseline and 8 weeks of the participants who were included in the analyses were reported. Mean (SE) of change from baseline outcome were reported, with adjusted group difference, 95% CI and associated p-value based on 1000 bootstrap samples. C, control group; CI, confidence interval; I, intervention group; SD, stand deviation; SE, stand error.